News | March 29, 2023
Thalassemics India celebrates 35 years of service in Thalassemia
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Expands robotics to 20+ specialities
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Proposed combination enhances Pfizer’s position as a leading company in oncology
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Subscribe To Our Newsletter & Stay Updated
